In conclusion, this study demonstrates that serum ATF4 levels are markedly increased in individuals with MASLD, while TLR4 elevation appears to reflect activation of inflammatory pathways. This evidence concerns the gene ATF4 and metabolic dysfunction-associated steatotic liver disease.